Our top pick for
JMP Group LLC is a capital markets business based in the US. JMP Group LLC shares (JMP) are listed on the NYSE and all prices are listed in US Dollars. JMP Group LLC employs 174 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$7.49|
|52-week range||$2.33 - $7.78|
|50-day moving average||$7.44|
|200-day moving average||$6.47|
|Wall St. target price||$7.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.53|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||0.13%|
|1 month (2021-09-21)||0.40%|
|3 months (2021-07-21)||23.60%|
|6 months (2021-04-21)||8.71%|
|1 year (2020-10-21)||192.58%|
|2 years (2019-10-21)||121.60%|
|3 years (2018-10-19)||47.73%|
|5 years (2016-10-21)||30.49%|
Valuing JMP Group LLC stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of JMP Group LLC's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
JMP Group LLC's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, JMP Group LLC shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
JMP Group LLC's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.07. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into JMP Group LLC's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$167.8 million|
|Operating margin TTM||10%|
|Gross profit TTM||$102.9 million|
|Return on assets TTM||4.97%|
|Return on equity TTM||17.01%|
|Market capitalisation||$149 million|
TTM: trailing 12 months
There are currently 40,818 JMP Group LLC shares held short by investors – that's known as JMP Group LLC's "short interest". This figure is 4.4% down from 42,694 last month.
There are a few different ways that this level of interest in shorting JMP Group LLC shares can be evaluated.
JMP Group LLC's "short interest ratio" (SIR) is the quantity of JMP Group LLC shares currently shorted divided by the average quantity of JMP Group LLC shares traded daily (recently around 113383.33333333). JMP Group LLC's SIR currently stands at 0.36. In other words for every 100,000 JMP Group LLC shares traded daily on the market, roughly 360 shares are currently held short.
However JMP Group LLC's short interest can also be evaluated against the total number of JMP Group LLC shares, or, against the total number of tradable JMP Group LLC shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case JMP Group LLC's short interest could be expressed as 0% of the outstanding shares (for every 100,000 JMP Group LLC shares in existence, roughly 0 shares are currently held short) or 0.0069% of the tradable shares (for every 100,000 tradable JMP Group LLC shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against JMP Group LLC.
Find out more about how you can short JMP Group LLC stock.
We're not expecting JMP Group LLC to pay a dividend over the next 12 months.
Over the last 12 months, JMP Group LLC's shares have ranged in value from as little as $2.33 up to $7.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while JMP Group LLC's is 0.9619. This would suggest that JMP Group LLC's shares are less volatile than average (for this exchange).
JMP Group LLC, together with its subsidiaries, provides investment banking, sales and trading, equity research, and asset management products and services in the United States. The company operates through Broker-Dealer, Asset Management Fee Income, and Investment Income segments. It offers various services, such as underwriting and acting as a placement agent for public and private capital markets raising transactions; and financial advisory services in mergers and acquisitions, restructuring, and other strategic transactions, as well as institutional brokerage services and equity research services. The company is also involved in the management of a range of pooled investment vehicles, including the hedge funds, private equity funds, hedge funds of funds, and collateralized loan obligations. In addition, it engages in investing in public and private securities, and investment funds, as well as other investing activities. The company also provides investment advisory services to business development companies. It serves corporates, institutional clients and investors, and high net-worth individuals.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.